Aim. The high frequency of cerebral blood flow causes the relevance of further study pathogenic mechanisms of cerebral ischemia and the search and study of highly cerebroprotector. In order to obtain comparative evaluation of the safety and neuroprotective effect of the drug Сerebroсurin the dependence of the effect on the ways of administration. Methods and results. Results of the study revealed the advantage of intrathecal route of administration before the intraperitoneal. The effect is manifested in increased survival of animals, decrease the manifestations of mitochondrial dysfunction, oxidative stress inhibition, activation of the antioxidant system in rat brain. Conclusion. The obtained results show the effectiveness of the ...
Developing new treatment strategies for acute ischemic stroke in the last twenty years has offered s...
Although a considerable body of scientific data is now available on neuroprotection in acute ischaem...
The aim. To study the cerebroprotective activity of a new derivative of 4-aminobutanoic acid the com...
Stroke is the leading cause of adult disability and remains the third most common cause of death in ...
The review discusses the role of neuroprotective therapy in the acute period of ischemic stroke in t...
Brain ischemia is a process of delayed neuronal cell death, not an instantaneous event. The concept ...
Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions Ischemi...
The best neuroprotectant for acute ischaemic stroke would always be the rapid return of oxygen and g...
The best neuroprotectant for acute ischaemic stroke would always be the rapid return of oxygen and g...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
Neuroprotection remains one of the holy grails of acute ischemic stroke therapy. The ability to prot...
Acute stroke still accounts for a significant proportion in the structure of all cardiovascular dise...
Efficacious treatment of acute stroke is a major challenge in modern medicine. Therapeutic neuroprot...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
The introduction of thrombolytic therapy has not only injected fresh optimism in stroke management, ...
Developing new treatment strategies for acute ischemic stroke in the last twenty years has offered s...
Although a considerable body of scientific data is now available on neuroprotection in acute ischaem...
The aim. To study the cerebroprotective activity of a new derivative of 4-aminobutanoic acid the com...
Stroke is the leading cause of adult disability and remains the third most common cause of death in ...
The review discusses the role of neuroprotective therapy in the acute period of ischemic stroke in t...
Brain ischemia is a process of delayed neuronal cell death, not an instantaneous event. The concept ...
Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions Ischemi...
The best neuroprotectant for acute ischaemic stroke would always be the rapid return of oxygen and g...
The best neuroprotectant for acute ischaemic stroke would always be the rapid return of oxygen and g...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
Neuroprotection remains one of the holy grails of acute ischemic stroke therapy. The ability to prot...
Acute stroke still accounts for a significant proportion in the structure of all cardiovascular dise...
Efficacious treatment of acute stroke is a major challenge in modern medicine. Therapeutic neuroprot...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
The introduction of thrombolytic therapy has not only injected fresh optimism in stroke management, ...
Developing new treatment strategies for acute ischemic stroke in the last twenty years has offered s...
Although a considerable body of scientific data is now available on neuroprotection in acute ischaem...
The aim. To study the cerebroprotective activity of a new derivative of 4-aminobutanoic acid the com...